Mucosal Healing Study in Crohn's Disease (CD)
NCT00297648
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
89
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Interventions
BIOLOGICAL:
Certolizumab pegol
Sponsor
UCB Pharma